Literature DB >> 29102165

Effect of Pregabalin and Diclofenac on tactile allodynia, mechanical hyperalgesia and pro inflammatory cytokine levels (IL-6, IL-1β) induced by chronic constriction injury of the infraorbital nerve in rats.

Junad Khan1, Noma Noboru2, Yoshiki Imamura2, Eli Eliav3.   

Abstract

The present study evaluated the effects of systemic pregabalin (PG) and diclofenac (Dic) on neuropathic orofacial pain induced by chronic constriction injury (CCI) of the infraorbital nerve (ION) and on the pro-inflammatory cytokines levels in the affected nerve. Fifty-four rats underwent left infra orbital nerve CCI, and 7 days after the procedure as the pain developed, the rats were randomly assigned to one of the treatment groups: PG 300, 30 or 10 mg/kg, Dic 10, 5 or 1 mg/kg or saline group (Sal) (n/group = 8). Addiitonal 8 rats served as naïve control group. Tactile-allodynia and Mechano-hyperalgesia were tested before the surgical procedure and at days 7, 8, and 9 postoperatively. On the 9th day, the rats were euthanized and the affected and contralateral sciatic nerves were harvested to assess IL-6 and IL-1β nerve levels employing enzyme linked immunosorbent assay (ELISA). Daily injection of PG (all doses) significantly reduced tactile-allodynia and mechano-hyperalgesia (p < .05) while Dic did not. On the 9th day, the ipsilateral nerve IL-6 levels were significantly decreased (p < .05) in the PG and DIC groups compared to the Sal group. IL-1β levels demonstrated a significant reduction (p < .05) in the PG group when compared to saline. These results suggest that PG but not Dic may be effective in reducing neuropathic orofacial pain. The mechanisms of action may be associated to some extent with reduction in IL-1β levels in the affected nerve.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  IL-1β; IL-6; Infraorbital nerve; Neuropathic; Orofacial; Pain; Pregabalin

Mesh:

Substances:

Year:  2017        PMID: 29102165     DOI: 10.1016/j.cyto.2017.10.003

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  5 in total

1.  Modulation of KIF17/NR2B crosstalk by tozasertib attenuates inflammatory pain in rats.

Authors:  Ankit Uniyal; Anagha Gadepalli; Ajay Modi; Vinod Tiwari
Journal:  Inflammopharmacology       Date:  2022-03-03       Impact factor: 4.473

2.  Interleukin 6 decreases nociceptor expression of the potassium channel KV1.4 in a rat model of hand-arm vibration syndrome.

Authors:  Pedro Alvarez; Oliver Bogen; Jon D Levine
Journal:  Pain       Date:  2019-08       Impact factor: 7.926

3.  Modulation of the In Vivo Inflammatory Response by Pro- Versus Anti-Inflammatory Intervertebral Disc Treatments.

Authors:  Carla Cunha; Graciosa Q Teixeira; Cláudia Ribeiro-Machado; Catarina L Pereira; Joana R Ferreira; Maria Molinos; Susana G Santos; Mário A Barbosa; Raquel M Goncalves
Journal:  Int J Mol Sci       Date:  2020-03-03       Impact factor: 5.923

4.  Pregabalin inhibits in vivo and in vitro cytokine secretion and attenuates spleen inflammation in Lipopolysaccharide/Concanavalin A -induced murine models of inflammation.

Authors:  Eman Y Abu-Rish; Ahmad T Mansour; Hebah T Mansour; Lina A Dahabiyeh; Shereen M Aleidi; Yasser Bustanji
Journal:  Sci Rep       Date:  2020-03-04       Impact factor: 4.379

Review 5.  Potential Molecular Targets for Treating Neuropathic Orofacial Pain Based on Current Findings in Animal Models.

Authors:  Yukinori Nagakura; Shogo Nagaoka; Takahiro Kurose
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.